SI1591122T1 - Postopek za aplikacijo bisfosfonatov - Google Patents
Postopek za aplikacijo bisfosfonatovInfo
- Publication number
- SI1591122T1 SI1591122T1 SI200131018T SI200131018T SI1591122T1 SI 1591122 T1 SI1591122 T1 SI 1591122T1 SI 200131018 T SI200131018 T SI 200131018T SI 200131018 T SI200131018 T SI 200131018T SI 1591122 T1 SI1591122 T1 SI 1591122T1
- Authority
- SI
- Slovenia
- Prior art keywords
- administering bisphosphonates
- bisphosphonates
- administering
- Prior art date
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/66—Phosphorus compounds
- A61K31/662—Phosphorus acids or esters thereof having P—C bonds, e.g. foscarnet, trichlorfon
- A61K31/663—Compounds having two or more phosphorus acid groups or esters thereof, e.g. clodronic acid, pamidronic acid
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P19/00—Drugs for skeletal disorders
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P19/00—Drugs for skeletal disorders
- A61P19/08—Drugs for skeletal disorders for bone diseases, e.g. rachitism, Paget's disease
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P19/00—Drugs for skeletal disorders
- A61P19/08—Drugs for skeletal disorders for bone diseases, e.g. rachitism, Paget's disease
- A61P19/10—Drugs for skeletal disorders for bone diseases, e.g. rachitism, Paget's disease for osteoporosis
Landscapes
- Health & Medical Sciences (AREA)
- Physical Education & Sports Medicine (AREA)
- Pharmacology & Pharmacy (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- General Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Life Sciences & Earth Sciences (AREA)
- Medicinal Chemistry (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Organic Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- General Chemical & Material Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Engineering & Computer Science (AREA)
- Rheumatology (AREA)
- Orthopedic Medicine & Surgery (AREA)
- Epidemiology (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Applications Claiming Priority (3)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US59713500A | 2000-06-20 | 2000-06-20 | |
US26768901P | 2001-02-09 | 2001-02-09 | |
EP05012711A EP1591122B1 (en) | 2000-06-20 | 2001-06-18 | Method of administering bisphosphonates |
Publications (1)
Publication Number | Publication Date |
---|---|
SI1591122T1 true SI1591122T1 (sl) | 2013-02-28 |
Family
ID=32595500
Family Applications (2)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
SI200131018T SI1591122T1 (sl) | 2000-06-20 | 2001-06-18 | Postopek za aplikacijo bisfosfonatov |
SI200130459T SI1296689T1 (sl) | 2000-06-20 | 2001-06-18 | Nacin dajanja pacientu bisfosfonatov |
Family Applications After (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
SI200130459T SI1296689T1 (sl) | 2000-06-20 | 2001-06-18 | Nacin dajanja pacientu bisfosfonatov |
Country Status (6)
Country | Link |
---|---|
EP (1) | EP1591122B1 (sl) |
DK (1) | DK1591122T3 (sl) |
LU (1) | LU92174I2 (sl) |
RU (1) | RU2288722C2 (sl) |
SI (2) | SI1591122T1 (sl) |
ZA (1) | ZA200210361B (sl) |
Families Citing this family (6)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
IN2012DN00845A (sl) * | 2009-07-21 | 2015-06-26 | Mylan Inc | |
PT2459176T (pt) | 2009-07-31 | 2017-12-11 | Gruenenthal Gmbh | Método de cristalização e biodisponibilidade |
US9169279B2 (en) | 2009-07-31 | 2015-10-27 | Thar Pharmaceuticals, Inc. | Crystallization method and bioavailability |
US20160016982A1 (en) | 2009-07-31 | 2016-01-21 | Thar Pharmaceuticals, Inc. | Crystallization method and bioavailability |
WO2012071517A2 (en) | 2010-11-24 | 2012-05-31 | Thar Pharmaceuticals, Inc. | Novel crystalline forms |
US10195218B2 (en) | 2016-05-31 | 2019-02-05 | Grunenthal Gmbh | Crystallization method and bioavailability |
Family Cites Families (7)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
ES2038692T4 (es) | 1986-11-21 | 2012-02-10 | Novartis Ag | Procedimiento para la obtencion de acidos alcanodifosfonicos substituidos. |
GB9408775D0 (en) | 1994-05-04 | 1994-06-22 | Ciba Geigy Ag | Use of certain methanebisphosphonic acid derivatives to prevent prothesis loosening and prothesis migration |
US6015801A (en) * | 1997-07-22 | 2000-01-18 | Merck & Co., Inc. | Method for inhibiting bone resorption |
FI109088B (fi) * | 1997-09-19 | 2002-05-31 | Leiras Oy | Tabletti ja menetelmä sen valmistamiseksi |
SE9703691D0 (sv) * | 1997-10-10 | 1997-10-10 | Astra Ab | Pharmaceutical compositions |
IT1296495B1 (it) * | 1997-11-21 | 1999-06-25 | Prodotti Antibiotici Spa | Impiego di bisfosfonati nella preparazione di forme farmaceutiche per somministrazione intramuscolare |
BR0010808A (pt) * | 1999-05-21 | 2002-08-27 | Novartis Ag | Composições farmacêuticas e usos |
-
2001
- 2001-06-18 SI SI200131018T patent/SI1591122T1/sl unknown
- 2001-06-18 EP EP05012711A patent/EP1591122B1/en not_active Expired - Lifetime
- 2001-06-18 DK DK05012711.7T patent/DK1591122T3/da active
- 2001-06-18 SI SI200130459T patent/SI1296689T1/sl unknown
- 2001-06-18 RU RU2003100503/14A patent/RU2288722C2/ru not_active IP Right Cessation
-
2002
- 2002-12-20 ZA ZA200210361A patent/ZA200210361B/xx unknown
-
2013
- 2013-03-22 LU LU92174C patent/LU92174I2/fr unknown
Also Published As
Publication number | Publication date |
---|---|
ZA200210361B (en) | 2003-11-13 |
SI1296689T1 (sl) | 2006-08-31 |
EP1591122B1 (en) | 2012-09-26 |
DK1591122T3 (da) | 2013-02-25 |
LU92174I2 (fr) | 2013-05-22 |
RU2288722C2 (ru) | 2006-12-10 |
EP1591122A1 (en) | 2005-11-02 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
HUP0301164A3 (en) | Method of administering bisphosphonates | |
HK1052183A1 (zh) | 製造tetrahydrobenzothiepines的方法 | |
IL213240A0 (en) | Method of treatment using lighnd-immunogen conjugates | |
PL363507A1 (en) | Pharmaceutical uses of bisphosphonates | |
GB0023983D0 (en) | Therapeutic compounds | |
GB0008710D0 (en) | Therapeutic compounds | |
HUP0302677A3 (en) | A method of alleviation the pain | |
GB0016681D0 (en) | Therapeutic compounds | |
AU6128301A (en) | Method of administering a bisphosphonate | |
EP1242200A4 (en) | METHOD FOR PRODUCING "T" COUPLINGS | |
GB2366639B (en) | Method of comparing parts | |
SI1591122T1 (sl) | Postopek za aplikacijo bisfosfonatov | |
EP1188441A4 (en) | ORAL PREPARATIONS OF DINATRIUM ETIDRONATE | |
AU5881001A (en) | Method of stabilizing preparation | |
GB0008921D0 (en) | Method of treatment | |
EP1267911A4 (en) | TREATMENT METHOD | |
IL138013A0 (en) | Method of safe infusion | |
GB0024938D0 (en) | Method of diagnosis | |
EP1303281A4 (en) | METHODS OF TREATMENT | |
AU8626801A (en) | Method of forming complex | |
GB0013105D0 (en) | Therapeutic compounds | |
AU2002366591A8 (en) | Method of administering calcium citrate | |
GB0002762D0 (en) | Method of treatment | |
GB0021476D0 (en) | Method of attachment | |
GB0013928D0 (en) | Methods of treatment |